Tirozinska proteinska kinaza 6 je enzim koji je kod ljudi kodiran PTK6genom.[2][3][4]
Funkcija
Tirozinska proteinska kinazae 6 (takođe poznata kao kinaza tumora dojke, Brk) je citoplazmna nereceptorska proteinska kinaza koja deluje kao intraćelijski prenosnik signala u epitelnim tkivima. Ovaj protein je podložan autofosforilaciji.[4]
Klinički značaj
Prekomerno izražavanja ovog gena u epitelnim ćelijama sisara dovodi do senzitizacije ćelija na epidermalni faktor rasta, što dovodi do parcijalno transformisanog fenotipa. Izražavanje ovog gena je detektovano u niskim nivoima u pojedinim tumorima dojke, do čega ne dolazi u normalnom tkivu dojke.[4]
↑PDB1rja; Hong E, Shin J, Kim HI, Lee ST, Lee W (July 2004). „Solution structure and backbone dynamics of the non-receptor protein-tyrosine kinase-6 Src homology 2 domain”. J. Biol. Chem.279 (28): 29700–8. DOI:10.1074/jbc.M313185200. PMID15056653.
↑Park SH, Lee KH, Kim H, Lee ST (September 1997). „Assignment of the human PTK6 gene encoding a non-receptor protein tyrosine kinase to 20q13.3 by fluorescence in situ hybridization”. Cytogenet Cell Genet77 (3–4): 271–2. DOI:10.1159/000134595. PMID9284935.
↑Mitchell, P J; Sara E A; Crompton M R (August 2000). „A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK”. Oncogene (ENGLAND) 19 (37): 4273–82. DOI:10.1038/sj.onc.1203775. ISSN0950-9232. PMID10980601.
Serfas MS, Tyner AL (2003). „Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases”. Oncol. Res.13 (6–10): 409–19. PMID12725532.
Kamalati T, Jolin HE, Mitchell PJ, et al. (1997). „Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor”. J. Biol. Chem.271 (48): 30956–63. DOI:10.1074/jbc.271.48.30956. PMID8940083.
Lee H, Kim M, Lee KH, et al. (1998). „Exon-intron structure of the human PTK6 gene demonstrates that PTK6 constitutes a distinct family of non-receptor tyrosine kinase”. Mol. Cells8 (4): 401–7. PMID9749526.
Llor X, Serfas MS, Bie W, et al. (1999). „BRK/Sik expression in the gastrointestinal tract and in colon tumors”. Clin. Cancer Res.5 (7): 1767–77. PMID10430081.
Mitchell PJ, Sara EA, Crompton MR (2000). „A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK”. Oncogene19 (37): 4273–82. DOI:10.1038/sj.onc.1203775. PMID10980601.
Kamalati T, Jolin HE, Fry MJ, Crompton MR (2000). „Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation”. Oncogene19 (48): 5471–6. DOI:10.1038/sj.onc.1203931. PMID11114724.
Hong E, Shin J, Bang E, et al. (2001). „Complete sequence-specific 1H, 13C and 15N resonance assignments of the human PTK6 SH2 domain”. J. Biomol. NMR19 (3): 291–2. DOI:10.1023/A:1011221125013. PMID11330822.
Deloukas P, Matthews LH, Ashurst J, et al. (2002). „The DNA sequence and comparative analysis of human chromosome 20”. Nature414 (6866): 865–71. DOI:10.1038/414865a. PMID11780052.
Kang KN, Kim M, Pae KM, Lee ST (2002). „Characterization of the 5'-flanking region of the human PTK6 gene”. Biochim. Biophys. Acta1574 (3): 365–9. DOI:10.1016/s0167-4781(02)00234-8. PMID11997104.
Qiu H, Miller WT (2002). „Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition”. J. Biol. Chem.277 (37): 34634–41. DOI:10.1074/jbc.M203877200. PMID12121988.
Koo BK, Kim MH, Lee ST, Lee W (2002). „Purification and spectroscopic characterization of the human protein tyrosine kinase-6 SH3 domain”. J. Biochem. Mol. Biol.35 (3): 343–7. DOI:10.5483/BMBRep.2002.35.3.343. PMID12297019.
Derry JJ, Prins GS, Ray V, Tyner AL (2003). „Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells”. Oncogene22 (27): 4212–20. DOI:10.1038/sj.onc.1206465. PMID12833144.